BioSpace.com News

AstraZeneca PLC Announces New $500 Million Cambridge Biomedical Campus HQ, Will Employ 2000 by 2016

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Pharmaceutical giant AstraZeneca has announced it is setting up its new global headquarters at the Cambridge Biomedical Campus. The 330m research and development (R&D) site is expected to employ about 2,0...

Norbrook Laboratories Launch Major Recruitment Drive for 400 New Jobs

Mon, 17 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Norbrook is a leading manufacturer of veterinary pharmaceuticals and contract manufactures for all of the top pharmaceutical companies in the world at its three plants in Newry. In recent years the company has...

Almac Group Announces Further Expansion and 229 New Jobs

Tue, 11 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ALMAC ANNOUNCES FURTHER EXPANSION AND 229 NEW JOBS

11th June 2013 -- Following the success of one of its key client partnered products, Craigavon-based pharmaceutical...

Boehringer Ingelheim Corporation to Build Biopharma Facility in China, Creating 65 Jobs

Fri, 07 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Germany's Boehringer Ingelheim is entering into a strategic alliance with Shanghai-based Zhangjiang Biotech & Pharmaceutical Base Development Company (ZJ Base Company) to construct a cGMP biopharmaceuticals...

BASF Seeks to Invest $10 Billion and Create 9,000 Jobs in Asia-Pacific by 2020

Tue, 04 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Hong Kong June 4, 2013 BASF is implementing its global We create chemistry strategy in Asia Pacific with a set of ambitious targets and a focus on sustainability. To achieve sales of 25 billion to customers...

Addex Therapeutics Terminates 17 Out of 19 Employees in Restructuring, CEO Steps Down

Mon, 03 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Addex Completes Restructuring to Focus on Capturing Potential Upside from its Partnered Asset and CEO Steps Down

Geneva, Switzerland, 31 May 2013 - Addex Therapeutics...

Pharmaxis Ltd Slashes 30 Pct. of Jobs

Tue, 28 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Pharmaxis Announces Outcome Of Business Review

Pharmaceutical company Pharmaxis (ASX:PXS) today announced a revised business plan...

Ranbaxy Laboratories Rumored to Cut One-Third of Global Sales Force, Mainly in U.S.: Source

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Even as trouble thickens for drug maker Ranbaxy Laboratories, the company is now considering downsizing its global sales force by around a third. A majority of the job cuts would be in the US, it is learnt...

GlaxoSmithKline to Shut Packaging Plant in Boronia, Laying Off 120 Workers

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SYDNEYGlaxoSmithKline GSK.LN 1.78% PLC said it would close an Australian tablet-packaging facility and lay off 120 workers, joining a string of manufacturers that have shut factories, slashed jobs and relocated...

Actavis "Moves" to Ireland for a Lower Tax Rate

Tue, 21 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

If there is a take-away message from the $8.5 billion deal in which Actavis is going to buy Warner-Chilcott, it would be that taxes matter. How so? As part of the acquisition, Actavis is going to declare its...

Bickering Continues Over Sanofi (France) R&D Site

Fri, 17 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Sanofi (SAN) and the French government presented conflicting views on plans for the future of the drugmakers research site in Toulouse, further complicating the companys reorganization attempts. Industry Minister...

Pfizer Inc. to Close Little Island Plant - 136 Jobs Lost

Wed, 15 May 2013 12:00:00 AM GMT

Hey, Pfizer's hiring! (Isnt it tempting?)

The jobs of more than 130 people are under threat at a manufacturing plant operated by pharmaceutical company Pfizer in Co Cork. Pfizer has said it plans to withdraw from the plant at Little Island over the next 18 months. However...

Millennium Pharmaceuticals, Inc. CEO Out as Takeda Pharmaceutical Co. Ltd. Reorganizes, Cuts Costs

Mon, 13 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Deborah Dunsire, the CEO who led Millennium Pharmaceuticals to prominence in cancer treatment, is leaving the company in an abrupt departure five years after it was acquired by Japan-based Takeda Pharmaceuticals...

PRA International, Inc.: 100 New Jobs Created as Company Expands

Thu, 09 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

An expansion of a clinical research company in Swansea will create 100 jobs, according to the firm. US company PRA is doubling the number of its employees in the city following 1.29m of Welsh government support...

Eli Lilly and Company Job Cuts Almost Double Original Numbers in Detailed Report

Wed, 08 May 2013 12:00:00 AM GMT

Hey, Eli Lilly's hiring! (Isnt it tempting?)

Eli Lilly and Co.s massive restructuring of its sales force will affect more employees than the Indianapolis-based drugmaker disclosed in early April. Lilly will eliminate 1,624 positions from its U.S. sales force in July, according...

Redx Pharma Creates 120 New Jobs at Site Being Vacated by AstraZeneca PLC

Tue, 07 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Liverpool-based Redx Pharma's new venture will create 120 jobs at the site, with a further 28 specialist roles expected to be created within the wider supply chain. The site is owned and operated by AZ, which...

Novo Nordisk A/S Invests $69 Million in Plant, Creating 50 New Production/Engineering Jobs

Tue, 07 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Novo Nordisk says the $69 investment in its Danish plant will convert capacity ready for its new GLP-1 analogue and is a further commitment to Danish manufacturing.

Help employers find you! Check...

Royalty Pharma Warns of Job Cuts if Elan Corporation PLC Bid Accepted

Mon, 06 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

New York investment firm Royalty Pharma has warned there could be job cuts in the Irish drug firm Elan if Royalty is successful in its 4.3bn takeover bid for the company. Royalty Pharma said last week...

Teva Pharmaceutical Industries Limited to Shut Down Pennsylvania Facility, Cutting Hundreds of Jobs

Fri, 03 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

With net income down 26.7 percent for the first quarter of this year, Teva Pharmaceutical Industries, Ltd., announced Thursday morning that it will close its manufacturing and research facility in Sellersville...

Lonza Inc. Closes Ireland Site as U.S. Manufacturing Issues Causes Shortage of Ipsen's Increlex

Wed, 01 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Manufacturing disruptions at Lonza's Hopkinton, Massachusetts site are causing shortages of Ipsen Biopharmaceuticals growth failure treatment for children in both the US and EU, just as the company announces...

Novartis AG Reduces 40 Pct of Its Total Nebraska Workforce

Thu, 25 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

April 24, 2013

Group net sales of USD 14.0 billion grew 2% (4% cc[1])

Core operating income of USD 3.7 billion (3%, 6% cc) grew ahead of sales, improving core operating income...

454 Life Sciences in Branford Laying Off 60 Workers

Wed, 24 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

A reorganization of a division of Swiss pharmaceutical giant Roche has hit home in Branford with the layoffs of 60 people at the companys 454 Life Sciences subsidiary. The layoffs were implemented Tuesday...

AstraZeneca PLC Hires Sioux Falls Company Which Plans to Add 50 Jobs

Wed, 17 Apr 2013 12:00:00 AM GMT

Biopharmaceutical giant AstraZeneca has hired a Sioux Falls company that plans to add 50 jobs to its growing workforce. MedVantx Pharmacy Services operates in relative obscurity in northeastern Sioux Falls. It opened in 2002 at 2503 E. 54th St. N. as a home-delivery pharmacy with four employees under the name AmeriPharm. At the time, the company mailed prescription drugs to patients on group health...

Pfizer Inc. Reduces Field Staff Base in India

Tue, 16 Apr 2013 12:00:00 AM GMT

Employees at global pharma giant Pfizer allege it is cutting its work force in India by insisting they take a voluntary retirement scheme (VRS). The said scheme appears to cover its field force, as well as managerial staff. The company has offered the VRS to at least 270-300 workers so far, sources said. According to them, this is notable as it comes within days of another pharma major, Novartis, losing...

Teva Pharmaceutical Industries Limited to Reduce Manufacturing Footprint, Chief Says

Fri, 12 Apr 2013 12:00:00 AM GMT

Teva Pharmaceutical Industries Ltd. (TEVA) is reducing manufacturing operations as part of a cost-cutting effort, though most of the savings under the plan will come from lowering procurement expenses, Chief Executive Officer Jeremy Levin said. Teva, the worlds biggest generic-drug maker, has set a goal of lowering expenses by as much as $2 billion over five years to increase long-term profitability...

Novartis AG Moving 120 Alcon Laboratories, Inc. Jobs to Massachusetts

Thu, 11 Apr 2013 12:00:00 AM GMT

Hey, Novartis is hiring! (Isnt it tempting?)

Swiss pharmaceutical giant Novartis said Tuesday that it is consolidating its U.S.-based eye disease research projects in Cambridge, Mass., and closing the Novartis Institutes for BioMedical Research group on its Alcon Labs campus in Fort Worth. About...

Novartis AG Creates 100 Jobs in Ireland

Tue, 09 Apr 2013 12:00:00 AM GMT

Hey, Novartis is hiring! (Isnt it tempting?)

Pharmaceutical company Novartis is to create 100 jobs in Dublin with the establishment of a new business services centre. The development will see consolidation of a range of the company's services including digital marketing, sales-force training and...

Phytopharm PLC Stopping R&D Spending, Cutting Headcount

Tue, 26 Mar 2013 12:00:00 AM GMT

Drug development company, Phytopharm, has begun talks with potential buyers for the company after it confirmed the results of its Phase II clinical trial of Cogane in Parkinson's disease, which showed that the drug had demonstrated no clinically meaningful efficacy. Those results were first announced in February, sparking a massive sell off in the company's stock which now trades at just over a tenth...

AstraZeneca PLC: 2300 More Layoffs; Global Total Now 5050

Fri, 22 Mar 2013 12:00:00 AM GMT

SDERTLJE, Sweden--(BUSINESS WIRE)--Regulatory News: AstraZeneca (STO:AZN) (LSE:AZN) will today outline its strategy to return to growth and achieve scientific leadership. Results of the annual strategy review will be presented at AstraZenecas Investor Day briefing in New York.

Chief Executive Officer, Pascal Soriot said: AstraZeneca is committed to delivering great medicines to patients...

Gerresheimer to Bring 120 Jobs to GA

Tue, 19 Mar 2013 12:00:00 AM GMT

A 180,000 square foot addition to a Peachtree City industry was approved by the Planning Commission Monday night. Beyond that big addition, the project is anticipated to make way for 120 or more new jobs at Gerresheimer, located off Ga. Highway 74 South in the citys industrial park. Gerresheimer is known as the European market leader for manufacturing medical drug-delivery plastic systems. It also...

AstraZeneca PLC to Axe 1600 Jobs in Major R&D Overhaul

Mon, 18 Mar 2013 12:00:00 AM GMT

AstraZeneca is to cut around 1,600 jobs as it overhauls it research operations and consolidates drug development work in three major centres. The move will see the end of drug research at the company's Alderley Park facility in northern England, for many years a hub of the group's R&D efforts, the drugmaker said on Monday.

Neurosearch A/S Takes Steps to Adjust the Organization and Updates on the Company's Strategy

Mon, 18 Mar 2013 12:00:00 AM GMT

March 18, 2013 -- The transfer of the Huntexil project to Teva Pharmaceutical Industries Ltd. (Teva) is now so advanced that the company foresees a significant reduction in the activity level in the near future. Therefore, the company takes measures to adjust the organisation to the lower activity level and at the same time updates on the company's strategy.

The Board of Directors and the...

GlaxoSmithKline to Close Sirtris Pharmaceuticals Cambridge Office, Relocate Some Staff to Philly

Wed, 13 Mar 2013 12:00:00 AM GMT

Pharmaceutical giant GlaxoSmithKline has now confirmed it is proposing to move staff from its research and development complex in Harlow next year (2014). In a statement released after the Star broke the news that the company is planning to close one of its buildings at Pinnacles, the company issued the following statement: We know that opportunities exist to increase collaboration across R&D by effective...

Loss of 400 Jobs as Baxter International, Inc. Invests $35 Million in Puerto Rico

Tue, 12 Mar 2013 12:00:00 AM GMT

Baxter is to cut 400 jobs at a facility in Puerto Rico as part of plans to realign its manufacturing business in North America. Affected workers are based at Baxter's plant in Aibonito, which manufactures injectable drugs and has a workforce of just under 1,000 employees. Local reports say that 100 positions will be gone by June 2013, with the remaining cuts to be implemented gradually. The layoffs...

Merck Serono: Fresh Pipeline Leads Growth but More Jobs Cuts to Come

Mon, 11 Mar 2013 12:00:00 AM GMT

Merck Serono says fast progress in its restructure programme helped double its net savings guidance for 2012 though headcount dropped by almost 2,000 with more cuts to come.

Teva Pharmaceutical Industries Limited to Cut Jobs Amid $2 Billion Cost-Cut Plan

Fri, 08 Mar 2013 12:00:00 AM GMT

Teva Pharmaceutical Industries Ltd. (TEVA) may be preparing to cut jobs in its home market of Israel even as local politicians criticize the company for paying too little in taxes. The worlds largest maker of generic drugs has pledged to cut costs by as much as $2 billion in the next five years as part of a new strategy to increase long-term profitability. Part of those savings will probably need...

Venezuelan Pharmaceutical Firm, Dubbed "" to Relocate to Florida, Bringing New Jobs

Thu, 07 Mar 2013 12:00:00 AM GMT

After considering Atlanta and other parts of Georgia, plus parts of Florida, a Venezuelan pharmaceutical company has decided to make Tamarac its home. The company, which is moving out of Venezuela partly because of the country's political and economic crises, has plans for a capital investment of $50 million and is expected to create 100 high-paying jobs over three years. It will manufacture prescription...

Merck Sharp & Dohme to Cut 280 Jobs in Wicklow, Plans to Cease Operations by 2015

Thu, 07 Mar 2013 12:00:00 AM GMT

Two hundred and eighty jobs are being cut at a pharmaceutical company in Co Wicklow. Staff at MSD's Rathdrum site were called to a meeting to discuss the cuts this morning. It is understood the cuts are part of a worldwide reduction in costs at the company. Their plant in Rathrdum will cease operations by the end of 2015. The company have been in Wicklow since 1961. Rathdrum has been a significant...

Enterprise Ireland Biotechnology Directorate: High Potential Start Ups to Create 1,600 Jobs

Thu, 07 Mar 2013 12:00:00 AM GMT

More than 1,600 new jobs are to be created by 97 new start-up companies supported by Enterprise Ireland in 2012. The companies, which are part of the government agencys high potential start-up unit, are set to generate over 300 million in annual sales and operate in a wide range of sectors including financial services, ICT, games, pharmaceuticals and medical devices.

Bruton Slammed as GlaxoSmithKline Cuts 94 Jobs

Tue, 19 Feb 2013 12:00:00 AM GMT

Minister for Jobs Richard Bruton has been urged to come to Cork to give a detailed response to the decision by GlaxoSmithKline (GSK) to axe 94 jobs at its Cork centre. The pharmaceutical giant is to let 94 jobs go over a phased basis at the GSK centre at Cork Airport Business Park. GSK is proposing to move all financial services roles from Cork to the UK this year, as part of a plan to simplify...

Up to 95 Jobs Cut at Huntingdon Life Sciences

Thu, 14 Feb 2013 12:00:00 AM GMT

Almost 100 people have lost their jobs at pharmaceutical laboratories in Cambridgeshire and Suffolk. In December, Huntingdon Life Sciences said staff would be consulted on the cuts at its headquarters in Alconbury and a centre in Eye. A spokesperson said about 95 people lost their jobs. Most left in January and others will finish on the completion of current projects.

Daiichi Sankyo, Inc. Reps Charge Sex Discrimination

Tue, 12 Feb 2013 12:00:00 AM GMT

Yet another drugmaker is being charged with alleged sex discrimination by female employees. The latest instance involves six current and former sales representatives for Daiichi Sankyo, who charge they were subject to discriminatory practices involving pay and promotions, as well as inapproriate conduct in the workplace. The lawsuit, which was filed yesterday in federal court in San Francisco, seeks...

Viehbacher Sees Sanofi (France) Growth in Diagnostics and Nutrition

Fri, 08 Feb 2013 12:00:00 AM GMT

Sanofis Chief Executive Officer Chris Viehbacher, whos completed 32 acquisitions and 91 licensing deals in four years, says more collaborations may be a way to grow in diagnostics and nutrition. I believe in this health-care approach, which means Sanofi is becoming a company focused on health, not just drugs, Viehbacher said in an interview at Sanofis Paris headquarters. Frances largest drugmaker...

GlaxoSmithKline Plans More Restructuring as Profit Sinks

Wed, 06 Feb 2013 12:00:00 AM GMT

British drugmaker GlaxoSmithKline on Wednesday announced a 13-percent drop in annual profits and said it would further restructure its European operations to deliver greater savings amid weaker sales across the region. GSK said profit after tax fell to 4.565 billion ($7.153 billion, 5.285 billion euros) in 2012 from 5.261 billion a year earlier.

IMSTec to Set Up R&D Center, New Jobs Coming

Tue, 29 Jan 2013 12:00:00 AM GMT

Kinsale is set to benefit from 35 new high-quality jobs with the announcement that German pharmaceutical solutions manufacturer IMSTec is to set up a service support and R&D centre in the West Cork town. The announcement was made by Enterprise Minister Richard Bruton as part of a wider announcement of 147 new jobs from US and European companies for Cork and Dublin in the ICT, medical technology, financial...

Almac Group Opens New Non-GMP Plant and Says "Send Us Your CV!"

Thu, 17 Jan 2013 12:00:00 AM GMT

A pharmaceutical company in Northern Ireland has announced plans to double capacity over the next three years - a move that could create up to 60 jobs. The expansion at Almac in Craigavon, Co Armagh, is expected to create between 50 and 60 new jobs as the facility develops. The posts will be in analytical and development roles as well as indirect support roles. Two new laboratories are to be built...

Job Cut Fears at AstraZeneca PLC's Research Hub

Tue, 15 Jan 2013 12:00:00 AM GMT

Fears of further job losses at AstraZeneca's research hub hub at Alderley Park, Cheshire were fuelled as its new chief executive Pascal Soriot re-examines priorities for research and development investment. Last year, the pharmaceutical giant, which employs more than 6,000 at sites in Macclesfield and Alderley Park, announced 7,300 job losses worldwide. This included up to 350 roles at Alderley Park...

Bavarian Nordic Consolidates its Vaccine Manufacturing in Denmark

Fri, 11 Jan 2013 12:00:00 AM GMT

KVISTGAARD, Denmark, January 11, 2013 - Bavarian Nordic A/S (OMX: BAVA) todayannounced that it will consolidate its manufacturing activities in Kvistgaard,Denmark with an aim to optimize productivity and profitability. As part of thisconsolidation, the company will prepare the Kvistgaard facility for the futurecommercial production of its prostate cancer vaccine, PROSTVAC and alsotransfer...

Valeant Pharmaceuticals International Shuts Down One Plant, More to Follow

Thu, 10 Jan 2013 12:00:00 AM GMT

Canadian firm Valeant Pharmaceuticals has closed down one of its facilities in Brazil and will shutter a second in the first half of this year as it trims down its manufacturing network. The plants were inherited by Valeant as part of its acquisition of Brazilian branded generic and over-the-counter medicines company Probiotica Laboratorios last year in a 150 million real ($85 million) deal. A second...

New Teva Pharmaceutical Industries Limited CEO Downplays Job Cuts in Reorg.

Wed, 09 Jan 2013 12:00:00 AM GMT

Jeremy Levin did not give a pass to all 46,000 employees of Teva Pharmaceuticals Ltd., but some might be happy to hear that the chief executive officer said Tuesday that reducing "head count" will play only a "small role" in the company's plans to cut $1.5 billion to $2 billion in costs in the next five years. Teva is based in Israel but has its Americas headquarters in North Wales, as well as facilities...

Redx Oncology Ltd to Create Another 60 Jobs

Thu, 03 Jan 2013 12:00:00 AM GMT

BIO-medical group REDX Pharma's cancer research subsidiary has launched a recruitment drive, which will see it nearly double in size. Redx Oncology, which launched in April last year and is backed to the tune of 6m by the Government's Regional Growth Fund, has already created 67 jobs and is looking to fill more than 60 high-value positions. Positions currently available at Redx Oncology range from...

SYGNIS Pharma AG to Discontinue Ongoing R&D Project, Trim Workforce

Thu, 20 Dec 2012 12:00:00 AM GMT

Heidelberg 20 December 2012 - SYGNIS Pharma AG (Frankfurt: LIO1; ISIN: DE000A1RFM03, Prime Standard) announced today the discontinuation of its therapeutic R&D project KIBRA and the adaptation of its organisation to the new business activity. At the Heidelberg site the staff will be reduced by 10 employees. These measures are implemented to concentrate the financial resources on the development...

Sanofi (France) to Establish New Faculty and Jobs in the Kingdom

Tue, 18 Dec 2012 12:00:00 AM GMT

Sanofi, a global diversified healthcare leader lays its foundation stone in King Abdullah Economic City. Sanofi will be first global pharmaceutical company to establish its industrial facility with a 100 percent foreign direct investment in the Kingdom, as it was given a unique opportunity to develop its independent presence in the Kingdom in the year 2011, by establishing itself as an independent...

LifeCell International's New Service Will Create Over 200 New Jobs

Tue, 18 Dec 2012 12:00:00 AM GMT

LifeCell International, Indias largest and most recommended stem cell storage company, has launched Indias first dual storage service, a unique initiative made possible with the inauguration of its new advanced stem cell centre in Gurgaon (Manesar) near New Delhi. LifeCells dual storage service allows customers to simultaneously store stem cells in two geographically distant locations, ensuring...

Jobs Lost at in Belfast

Tue, 18 Dec 2012 12:00:00 AM GMT

Almost 40 staff at a Northern Ireland engineering firm have been laid off after administrators were appointed. FIN Engineering Limited was part of the FIN Group, which was incorporated in 1990 and was renamed in 1998, following the acquisition of Nucap Services. The company's headquarters are based on the Saintfield Road, Belfast, with a regional office in Birmingham. The firm specialised in capital...

Macleods Pharma to Put $25 Million to Work, New Plant and Jobs Coming

Fri, 14 Dec 2012 12:00:00 AM GMT

Indian drugmaker M?cleods Pharmaceuticals plans to invest up to 700 million roubles (around $25 million) in the construction of a plant for the production of antituberculous drugs in Russias Belgorod region by 2016. The project is expected to be implemented by the local Advanced Trading company, an official supplier of M?cleods drugs in the Russian market, which currently accounts for 25% of the Russian...

Up to 100 Jobs to Go at Huntingdon Life Sciences as Another Round of Redundancies Announced Before Christmas

Thu, 13 Dec 2012 12:00:00 AM GMT

The international contract research organisation said it was having to cut approximately 8 per cent of its workforce at its Huntingdonshire site because it simply does not have enough work coming in from the pharmaceutical industry around the world. A spokesman for HLS, which helps to develop medicines for pharmaceutical, biopharmaceutical, crop protection and chemical businesses, said it was being...

Teva Pharmaceutical Industries Limited CEO Vows Cost Cuts, Deals, Divestitures in Reshaping Drug Maker; to End 5 Research Programs

Thu, 13 Dec 2012 12:00:00 AM GMT

Teva Pharmaceutical Industries Ltd.'s (TEVA) new leader vowed to reshape the drug maker, including a reduction in annual costs of up to $2 billion over the next five years. Jeremy Levin, who took over the Israel-based company in May, also said Tuesday in a meeting with analysts and investors in New York he would pursue small- to mid-sized acquisitions, as well as divestitures of certain non-core assets...

Billionaires Push to Turn Ex-Merck Serono HQs Into R&D Center, New Jobs

Tue, 11 Dec 2012 12:00:00 AM GMT

06.12.12 - A dedicated Consortium comprised of the cole Polytechnique Fdrale de Lausanne (EPFL), the University of Geneva (UNIGE), Dr Hansjrg Wyss and the Bertarelli family has developed a project to convert part of the former Merck Serono site in Geneva into a multi-development facility. The project, "Campus Biotech", will be a center of excellence in healthcare, biotechnology and life sciences...

Amarin Corporation PLC Gets Sales Staff and $100 Million Financing for Vascepa

Fri, 07 Dec 2012 12:00:00 AM GMT

BEDMINSTER, N.J., and DUBLIN, Ireland, Dec. 6, 2012 (GLOBE NEWSWIRE) -- Amarin Corporation plc (AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today a $100 million non-equity financing with an investment fund managed by Pharmakon Advisors and that Amarin is continuing its preparations to commercialize Vascepa...

Pfizer Inc. and the Incredible Shrinking Sales Force

Fri, 07 Dec 2012 12:00:00 AM GMT

Once again, Pfizer is cutting its sales force. As part of what has become a never-ending reorganization, the drugmaker is eliminating between 10 percent and 20 percent of its primary care sales team across the US, according to sources. Formal notification is expected to be issued to employees by December 20. The precise number of jobs to be cut is unclear and a Pfizer spokesman declined to provide...

AstraZeneca PLC to Cut 625 Jobs

Thu, 06 Dec 2012 12:00:00 AM GMT

The bleeding continues. AstraZeneca is eliminating up to 625 jobs from its operations in Germany in response to difficulties replenishing its product pipeline and pricing cuts imposed by the government, according to a statement on its web site. The cuts are being made due to delays in the research and development of new drugs as well as to massive state intervention in the pricing of innovative medicines...

Wilex AG Restructures, Cuts Jobs

Wed, 05 Dec 2012 12:00:00 AM GMT

Munich, Germany, 4 December 2012 WILEX AG (ISIN DE0006614720 / WL6 / FWB) has agreed a package of restructuring measures with the companys Supervisory Board. The Executive Management Board is reacting to the results of the Phase III ARISER study with RENCAREX, which missed the primary endpoint. The measures are designed to tailor development activities to the remaining projects, reduce the risks...

Sandoz, Inc. Closes Med Plant; Cuts 150 Jobs

Tue, 04 Dec 2012 12:00:00 AM GMT

Drug-maker Sandoz is shutting down its finished medicine development centre in Mumbai. Sandoz recently optimised its development centre network in alignment with its long-term development strategy, to better leverage existing technology and expertise, said Ranjit Shahani, Vice-Chairman and Managing Director, Novartis India Ltd. The decision to close the centre in Mumbai was aligned to this business...

GlaxoSmithKline Hopes for 14 New Drug Successes in 2013-14

Tue, 04 Dec 2012 12:00:00 AM GMT

GlaxoSmithKline expects to have pivotal clinical trial results on up to 14 medicines in the next two years, including two new products which - if they work - could change the way cancer and heart disease are treated. Unveiling the next wave of its pipeline on Monday, Britain's biggest drugmaker said it was now developing a broader range of drugs than in the past, as it moves away from the industry...

Albany Molecular Research, Inc. (AMRI) to Close U.S. Site & Shift Work to N.Y. and Singapore

Mon, 03 Dec 2012 12:00:00 AM GMT

AMRI says the decision to close its second discovery services facility in a year and shift work to Asia reflects changing market demand. The contract services frim announced the move last week, explaining that it will transfer discovery operations from Its leased facility in Bothell, Washington to its site in Singapore and move structural analysis work to Its laboaratory in Albany, New York.

Teva Pharmaceutical Industries Limited Plans Sweeping Reorganization

Mon, 03 Dec 2012 12:00:00 AM GMT

Teva Pharmaceutical Industries Ltd , the world's biggest maker of generic drugs, announced an ambitious plan on Friday to reshape the company as it faces increased competition for its top-selling multiple sclerosis drug Copaxone. The Israeli-based company said it plans to streamline operations, cut costs and make targeted acquisitions to improve profitability. It will discontinue certain research programs...

Spherix Announces Restructuring

Mon, 03 Dec 2012 12:00:00 AM GMT

BETHESDA, Md., Dec. 3, 2012 (GLOBE NEWSWIRE) -- Spherix Incorporated (SPEX) -- today announced that, as an initial step in its restructuring program, it has sold all of the stock of Spherix Consulting, Inc. to ChromaDex, Inc. Dr. Claire Kruger will continue to lead Spherix Consulting, the company she founded in 2008, as a division of ChromaDex. ChromaDex is an innovative natural products company that...

GlaxoSmithKline to Cut Jobs as it Reorganizes Pharma Unit

Fri, 30 Nov 2012 12:00:00 AM GMT

GlaxoSmithKline (GSK) announced a change to the business focus and organisational structure of its pharmaceutical division, based in Melbourne, yesterday. These changes will result in the reduction of about 90 positions from the pharmaceutical business, but will not impact manufacturing. Geoff McDonald, GSKs general manager pharmaceuticals said the job cuts came as a result of difficult conditions...

Novartis Warns Jobs May Go Overseas

Tue, 27 Nov 2012 12:00:00 AM GMT

The Government must tackle the red-tape and research hold-ups hampering Britains pharmaceutical industry or risk seeing jobs and investment disappear overseas, one of the industrys leading companies has warned. Swiss pharmaceuticals giant Novartis has arranged a crisis meeting of scientists, NHS trustees and Government officials starting today in London in a bid to streamline Britains haphazard...

Takeda Pharmaceutical Co. Ltd. Adding Biotech Jobs in La Jolla

Mon, 26 Nov 2012 12:00:00 AM GMT

Takeda Pharmaceuticals has acquired Envoy Therapeutics in a deal that will add 20 biotech jobs in La Jolla, where the firm focuses on cancer, immunology and metabolic diseases. Terms of the acquisition were not announced. Takeda consolidated its San Francisco and La Jolla operations earlier this year, bringing the company's total workforce locally to about 200. Now comes the deal for Florida-based...

Catalent Pharma Solutions Lays Off 40 Workers at UK Facility

Mon, 19 Nov 2012 12:00:00 AM GMT

Employees at a pharmaceutical company have been dealt a massive blow just weeks before Christmas, as it was announced dozens of staff would lose their jobs. More than 40 staff at Catalent have been told this week that they are to be without a job by the end of the year, along with several temporary staff. It has been confirmed by the company, which employs 500 staff at its base in Frankland Road, Blagrove...

Gilead Sciences, Inc. Quietly Plans Expansion, to Hire R&D Staff

Wed, 14 Nov 2012 12:00:00 AM GMT

BusinessWire Nov. 13, 2012 -- Gilead Alberta ULC, a wholly-owned subsidiary of Gilead Sciences, Inc. (Nasdaq: GILD), today announced that the company has entered an agreement with Eco Industrial Business Park Inc. to purchase and develop 10 acres of land at 1250 Hayter Road, in North East Edmonton. The transaction is anticipated to close in January 2013.

The agreement will allow for construction...

GlaxoSmithKline to Create 150 New Jobs in Malaysia Within 2 Years

Fri, 02 Nov 2012 12:00:00 AM GMT

GlaxoSmithKline (GSK) is expected to further create 150 job opportunities in Malaysia in the next two years, on top of the RM18 million investment in its new global shared serice hub called Business Service Centre (BSC).

Gary Forbes, Head of BSC, GSK, one of the global leaders in pharmaceutical and consumer healthcare products, said Malaysia will be home to the only BSC in the Asian region...

Thousands of Science Jobs Could be Created at Former Pfizer Inc. Site in Kent

Thu, 01 Nov 2012 12:00:00 AM GMT

Discovery Park, a private consortium which bought the pharmaceutical giants research site in August, said it would take advantage of the sites new Enterprise Zone status and tax reliefs for science companies as an incentive to attract global brands to the site.

Under Coalition rules, sites that have been granted Enterprise Zone status enjoy lower business rates, reduced planning restrictions...

Lonza Group Ltd. Axes 500 Jobs to Cut Costs

Thu, 01 Nov 2012 12:00:00 AM GMT

Swiss drugs industry supplier Lonza plans to cut 500 jobs, including 400 at its main plant in southern Switzerland, as it grapples with low-cost competition, a strong Swiss franc and higher raw material prices.

The cuts at the Basel-based firm, which makes pharmaceutical ingredients for drugmakers such as GlaxoSmithKline and Abbott, equate to around 5 percent of its global workforce of about...

UK's Redx Pharma to Create 100 New Jobs

Fri, 19 Oct 2012 12:00:00 AM GMT

DRUGS firm Redx Pharma is creating more than 100 jobs under a Government funding scheme.

The Government today announced the latest winners of 1bn in grants under its Regional Growth Fund (RGF) to boost the British economy.

Teva Pharmaceutical Industries Limited to Cut 65 in Irvine

Fri, 19 Oct 2012 12:00:00 AM GMT

Generic drug maker Teva Pharmaceuticals Inc. is cutting 65 jobs at its Irvine plant, according to a state filing. The cuts will take effect Oct. 29 and include a number of positions, including scientists, chemists, and inspectors. Teva, which is based in Israel and has its U.S. headquarters outside of Philadelphia, had an estimated 500 workers in Irvine before the filing, according to the Business...

120 Jobs Saved at GlaxoSmithKline Owned Stiefel Laboratories in Sligo

Mon, 15 Oct 2012 12:00:00 AM GMT

GlaxoSmithKline said it would invest 10 million in its plant in Sligo, saving it from closure and securing 120 jobs. The company told staff this morning that the Stiefel plant, which had been due to close next year, will move to from producing pharmaceutical products to consumer and eventually skin healthcare products. There will be some jobs cuts at the plant over the next two years, which currently...

Johnson & Johnson Opens New $63.5 Million Distribution Hub in Europe; Will Employ 115 People

Fri, 05 Oct 2012 12:00:00 AM GMT

Janssen has opened a new distribution centre in Belgium this week, creating a major new European hub for the firm. The European distribution centre centralises the activities of 15 logistics centres, enabling medicines from the different European production sites to be shipped directly to a single site. Tom Heyman, chief executive of Janssen Pharmaceutica, said: The European distribution centre in...